Shwu‐Luan Lee

Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes

Edvardas Kaminskas, Ann Farrell, Sophia Abraham et al. · Clinical Cancer Research · 2005 · 417 citations

Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma

Peter Bross, Robert C. Kane, Ann T. Farrell et al. · Clinical Cancer Research · 2004 · 336 citations · Full text

An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs)

Amy M. Avila, Ilona Bebenek, Jessica A. Bonzo et al. · Regulatory Toxicology and Pharmacology · 2020 · 176 citations

Fda/cder Perspective, Preclinical Drug Evaluation, Pharmacology +8

FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia

R. Angelo de Claro, Karen M. McGinn, Nicole Verdun et al. · Clinical Cancer Research · 2015 · 156 citations

Preclinical Therapeutics, Tyrosine Kinase, Pathology +18

FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation

Michael H. Brave, Ann T. Farrell, Sue Ching Lin et al. · Oncology · 2010 · 140 citations